Company Filing History:
Years Active: 2003
Title: Ya-Li Deng: Pioneering Innovations in Cancer Treatment
Introduction
Ya-Li Deng is an accomplished inventor based in San Diego, California, known for her significant contributions to the field of biomedical research. With a profound focus on inhibitor discovery, she has made strides in understanding critical processes during cell cycles that can impact treatments for serious diseases such as cancer and HIV.
Latest Patents
Ya-Li holds a patent for her invention titled "Catalytic domain of the human effector cell cycle checkpoint protein kinase materials and methods for identification of inhibitors thereof." This innovative patent outlines the identification, isolation, and purification of the catalytic domain of the human effector checkpoint protein kinase (hChk1). It also reveals a detailed crystal structure of the hChk1 kinase domain, which facilitates the discovery and development of potential inhibitors that could serve as therapeutic agents for hyperproliferative disorders, including cancer.
Career Highlights
Ya-Li Deng currently works at Agouron Pharmaceuticals, Inc., where her research continues to focus on the interaction mechanisms of cellular proteins and the therapeutic potential of their inhibitors. Her work has been essential in driving forward innovative solutions in fighting serious health challenges.
Collaborations
In her endeavors, Ya-Li collaborates with esteemed colleagues such as Ping Chen and Mark Brian Anderson. Together, they strive to advance the scientific understanding of hChk1 and the role of its inhibitors, further maximizing the impact of their research in clinical applications.
Conclusion
Ya-Li Deng's pioneering work exemplifies the crucial relationship between innovation and health care. With her patent on the hChk1 kinase domain, she stands at the forefront of research that holds promise in treating formidable diseases like cancer. As her work progresses, the biomedical community watches closely to see the transformative effects of her inventions on patient care and treatment methodologies.